
Can Ozempic Cure Addiction?
About this episode
Semaglutide, better known by its brand name Ozempic, has been making headlines as a weight loss drug – despite only having FDA approval to treat diabetes. Now, some say it doesn’t just quell cravings for food – it helps quiet cravings for alcohol, drugs, and other compulsive behaviors. For years, researchers have been studying semaglutide's effectiveness as an addiction cure in animals. What have they found? And – does it actually work?
Guest: Sarah Zhang covers health and medicine for The Atlantic
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Amicus—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time What Next: TBD | Tech, power, and the future publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from What Next: TBD | Tech, power, and the future

Meta Settled. Is it a "Reckoning?"
What Next: TBD | Tech, power, and the future

A.I. Enshittifies Everything (Still)
What Next: TBD | Tech, power, and the future

Can the Midterms Withstand Prediction Markets?
What Next: TBD | Tech, power, and the future

Are Flock Cameras Watching You?
What Next: TBD | Tech, power, and the future